Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    IRadimed Corporation

    NASDAQ: IRMD · Real-Time Price · USD
    58.41
    0.24 (0.41%)
    At close: Jun 16, 2025, 3:59 PM
    58.52
    0.18%
    After-hours: Jun 16, 2025, 04:04 PM EDT

    IRadimed Statistics

    Share Statistics

    IRadimed has 12.72M shares outstanding. The number of shares has increased by 0.4% in one year.

    Shares Outstanding

    n/a
    		 12.72M

    Shares Change (YoY)

    n/a
    		 0.4%

    Shares Change (QoQ)

    n/a
    		 0.33%

    Owned by Institutions (%)

    n/a
    		 54.92%

    Shares Floating

    n/a
    		 8.02M

    Failed to Deliver (FTD) Shares

    n/a
    		 7

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 229.52K, so 1.81% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 229.52K

    Short % of Shares Out

    n/a
    		 1.81%

    Short % of Float

    n/a
    		 2.86%

    Short Ratio (days to cover)

    n/a
    		 6.06

    Valuation Ratios

    The PE ratio is 36.23 and the forward PE ratio is 29.15. IRadimed's PEG ratio is 3.08.

    PE Ratio

    n/a
    		 36.23

    Forward PE

    n/a
    		 29.15

    PS Ratio

    n/a
    		 9.51

    Forward PS

    n/a
    		 8.5

    PB Ratio

    n/a
    		 8.03

    P/FCF Ratio

    n/a
    		 39.55

    PEG Ratio

    n/a
    		 3.08
    Financial Ratio History

    Enterprise Valuation

    IRadimed has an Enterprise Value (EV) of 644.78M.

    EV / Sales

    n/a
    		 8.8

    EV / EBITDA

    n/a
    		 28.3

    EV / EBIT

    n/a
    		 25.16

    EV / FCF

    n/a
    		 36.59

    Financial Position

    The company has a current ratio of 8.84, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 8.84

    Quick Ratio

    n/a
    		 7.62

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 0.01

    Debt / FCF

    n/a
    		 0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 22.15% and Return on Invested Capital is 19.34%.

    Return on Equity

    n/a
    		 22.15%

    Return on Assets

    n/a
    		 19.56%

    Return on Invested Capital

    n/a
    		 19.34%

    Revenue Per Employee

    n/a
    		 $457,763.26

    Profits Per Employee

    n/a
    		 $120,212.66

    Employee Count

    n/a
    		 160

    Asset Turnover

    n/a
    		 0.74

    Inventory Turnover

    n/a
    		 1.62

    Taxes

    Income Tax

    n/a
    		 5.04M

    Effective Tax Rate

    n/a
    		 20.77%

    Stock Price Statistics

    The stock price has increased by 35.71% in the last 52 weeks. The beta is 0.93, so IRadimed's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.93

    52-Week Price Change

    n/a
    		 35.71%

    50-Day Moving Average

    n/a
    		 54.07

    200-Day Moving Average

    n/a
    		 53.5

    Relative Strength Index (RSI)

    n/a
    		 57.52

    Average Volume (20 Days)

    n/a
    		 36,942

    Income Statement

    In the last 12 months, IRadimed had revenue of 73.24M and earned 19.23M in profits. Earnings per share was 1.52.

    Revenue

    n/a
    		 73.24M

    Gross Profit

    n/a
    		 56.35M

    Operating Income

    n/a
    		 21.96M

    Net Income

    n/a
    		 19.23M

    EBITDA

    n/a
    		 22.78M

    EBIT

    n/a
    		 21.96M

    Earnings Per Share (EPS)

    n/a
    		 1.52
    Full Income Statement

    Balance Sheet

    The company has 52.23M in cash and 154.69K in debt, giving a net cash position of 52.08M.

    Cash & Cash Equivalents

    n/a
    		 52.23M

    Total Debt

    n/a
    		 154.69K

    Net Cash

    n/a
    		 52.08M

    Retained Earnings

    n/a
    		 56.79M

    Total Assets

    n/a
    		 101.73M

    Working Capital

    n/a
    		 66.66M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 25.62M and capital expenditures -8.01M, giving a free cash flow of 17.62M.

    Operating Cash Flow

    n/a
    		 25.62M

    Capital Expenditures

    n/a
    		 -8.01M

    Free Cash Flow

    n/a
    		 17.62M

    FCF Per Share

    n/a
    		 1.39
    Full Cash Flow Statement

    Margins

    Gross margin is 76.94%, with operating and profit margins of 29.99% and 26.26%.

    Gross Margin

    n/a
    		 76.94%

    Operating Margin

    n/a
    		 29.99%

    Pretax Margin

    n/a
    		 33.14%

    Profit Margin

    n/a
    		 26.26%

    EBITDA Margin

    n/a
    		 31.11%

    EBIT Margin

    n/a
    		 29.99%

    FCF Margin

    n/a
    		 24.06%

    Dividends & Yields

    IRMD pays an annual dividend of $0.79, which amounts to a dividend yield of 1.2%.

    Dividend Per Share

    n/a
    		 $0.79

    Dividend Yield

    n/a
    		 1.2%

    Dividend Growth (YoY)

    n/a
    		 13.33%

    Payout Ratio

    n/a
    		 50.97%

    Earnings Yield

    n/a
    		 2.76%

    FCF Yield

    n/a
    		 2.53%
    Dividend Details

    Analyst Forecast

    The average price target for IRMD is $72, which is 23.3% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $72

    Price Target Difference

    n/a
    		 23.3%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $38

    Lynch Upside

    n/a
    		 -34.94%

    Graham Number

    n/a
    		 15.3

    Graham Upside

    n/a
    		 -73.81%

    Scores

    Altman Z-Score

    n/a
    		 39.27

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist